Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Relationships Between GLP-2 and Markers of Bone Turnover Following Feeding

View source ↗

Summary

A completed study examined how glucagon-like peptide-2 (GLP-2) relates to markers of bone turnover after feeding in people with obesity, aiming to understand gu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-2 (glucagon-like peptide-2)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Obesity | Status: COMPLETED